Risk Factors, Pathological Changes, and Potential Treatment of Diabetes‐Associated Cognitive Dysfunction
Journal of Diabetes · 2025-04 · 17 (4)
DOI: 10.1111/1753-0407.70089 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes, online erschienen am 28.04.2025. Verfasst von Xiaoyu Meng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, W…. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Diabetes Complications. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 329 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes is a prevalent public health issue worldwide, and the cognitive dysfunction and subsequent dementia caused by it seriously affect the quality of life of patients.
Methods
Recent studies were reviewed to provide a comprehensive summary of the risk factors, pathogenesis, pathological changes and potential drug treatments for diabetes‐related cognitive dysfunction (DACD).
Results
Several risk factors contribute to DACD, including hyperglycemia, hypoglycemia, blood sugar fluctuations, hyperinsulinemia, aging, and others. Among them, modifiable risk factors for DACD include blood glucose control, physical activity, diet, smoking, and hypertension management, while non‐modifiable risk factors include age, genetic predisposition, sex, and duration of diabetes. At the present, the pathogenesis of DACD mainly includes insulin resistance, neuroinflammation, vascular disorders, oxidative stress, and neurotransmitter disorders.
Conclusions
In this review, we provide a comprehensive summary of the risk factors, pathogenesis, pathological changes and potential drug treatments for DACD, providing information from multiple perspectives for its prevention and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Wuhan, China.
- Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, China.
- Department of Orthopaedics, Zhoukou Central Hospital, Zhoukou, China.
- Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Computer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Xiaoyu Meng, Yan Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Meng, X., Du, H., Li, D., Guo, Y., Luo, P., Pan, L., Kan, R., Yu, P., Xiang, Y., Mao, B., He, Y., Wang, S., Li, W., Yang, Y., & Yu, X. (2025). Risk Factors, Pathological Changes, and Potential Treatment of Diabetes‐Associated Cognitive Dysfunction. Journal of Diabetes, 17(4). https://doi.org/10.1111/1753-0407.70089
Vancouver
Meng X, Du H, Li D, Guo Y, Luo P, Pan L, et al. Risk Factors, Pathological Changes, and Potential Treatment of Diabetes‐Associated Cognitive Dysfunction. Journal of Diabetes. 2025;17(4). doi:10.1111/1753-0407.70089
BibTeX
@article{Meng2025,
author = {Meng, Xiaoyu and Du, Haiyang and Li, Danpei and Guo, Yaming and Luo, Peiqiong and Pan, Limeng and Kan, Ranran and Yu, Peng and Xiang, Yuxi and Mao, Beibei and He, Yi and Wang, Siyi and Li, Wenjun and Yang, Yan and Yu, Xuefeng},
title = {Risk Factors, Pathological Changes, and Potential Treatment of Diabetes‐Associated Cognitive Dysfunction},
journal = {Journal of Diabetes},
year = {2025},
volume = {17},
number = {4},
doi = {10.1111/1753-0407.70089}
}
EUVIMED